Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
Rajwa P, Quhal F, Pradere B, Gandaglia G, Ploussard G, Leapman MS, Gore JL, Paradysz A, Tilki D, Merseburger AS, Morgan TM, Briganti A, Palapattu GS, Shariat SF.
Rajwa P, et al. Among authors: gore jl.
Nat Rev Urol. 2023 Apr;20(4):205-216. doi: 10.1038/s41585-022-00680-4. Epub 2023 Jan 4.
Nat Rev Urol. 2023.
PMID: 36600087
Review.